Effects of letrozole co-treatment on the cumulative live-birth rate among normal responders in gonadotropin-releasing hormone antagonist cycles

Effects of letrozole co-treatment on the cumulative live-birth rate among normal responders in gonadotropin-releasing hormone antagonist cycles

Studies have shown that letrozole cotreatment can improve clinical outcomes in high and poor responders in GnRH-antagonist protocol. However, whether letrozole is also beneficial to normal responders is not known. To investigate the clinical value of letrozole cotreatment during ovarian stimulation...

Full description

Bibliographic Details
Main Authors:	Shuyi Zhang, Fumei Gao, Min Fu, Huan Shen, Yanbin Wang, Hongjing Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Medicine
Subjects:	cumulative live-birth rate letrozole GnRH antagonist normal responder ovary stimulation
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.1070583/full

Similar Items

Evaluation of the Impact of Letrozole in Combination with the GnRH Antagonist Ovarian Stimulation Protocol in Patients Expected to Have a Poor Ovarian Response (POSEIDON Groups 3 and 4)
by: Bulut Varlı, et al.
Published: (2024-02-01)

Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations
by: Ruiqiong Zhou, et al.
Published: (2023-04-01)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
by: Kristof Chwalisz, M.D., Ph.D.
Published: (2023-06-01)

Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
by: Fabrizio Fontana, et al.
Published: (2020-12-01)

Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval
by: Tzu-Ching Kao, et al.
Published: (2023-01-01)

Comparison of Controlled Ovarian Stimulation Protocols on IVF Outcome in Normal and Poor Responders
by: Deniz Esinler, et al.
Published: (2016-05-01)

GnRH Antagonist Protocol Versus GnRH Agonist Long Protocol: A Retrospective Cohort Study on Clinical Outcomes and Maternal-Neonatal Safety
by: Jieru Zhu, et al.
Published: (2022-06-01)

Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration
by: Jacques Donnez, et al.
Published: (2021-12-01)

Effects of different gonadotropin preparations in GnRH antagonist protocol for patients with polycystic ovary syndrome during IVF/ICSI: a retrospective cohort study
by: Zhengyan Hu, et al.
Published: (2024-02-01)

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2016-05-01)

Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis
by: Liting Zhang, et al.
Published: (2022-12-01)

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium
by: Depeng Zhao, et al.
Published: (2023-01-01)

Effect modification by developmental stage of embryos on the association between late follicular phase progesterone elevation and live birth in fresh transfers
by: Fei Li, et al.
Published: (2023-01-01)

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
by: Shen Zhao, et al.
Published: (2023-01-01)

Comparison of the Effects of Gonadotropin Releasing Hormone Agonists and Antagonists on Endometrial Development in Women who Had Inadequate Endometrial Development in a Previous Assisted Reproduction Treatment Cycle; A Randomised Parallel Group Pilot Trial
by: Özkan Aydın Leylek, et al.
Published: (2008-12-01)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
by: Andrea Roberto Carosso, et al.
Published: (2021-03-01)

Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?
by: Anna Maria Rzewuska, et al.
Published: (2023-01-01)

Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus GnRH agonist for prostate cancer treatment: A systematic review and meta-analysis
by: Li Gu, et al.
Published: (2023-03-01)

Neurobiological study of fish brains gives insights into the nature of Gonadotropin-releasing hormone 1-3 neurons.
by: Tomomi eKarigo, et al.
Published: (2013-11-01)

Recombinant LH supplementation improves cumulative live birth rates in the GnRH antagonist protocol: a multicenter retrospective study using a propensity score-matching analysis
by: Meng Wang, et al.
Published: (2022-08-01)

Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients
by: Yaxin Guo, et al.
Published: (2021-08-01)

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine
by: Farrah L. Saleh, M.D., et al.
Published: (2023-06-01)

Clinical Effects of a Microdose GnRH Agonist Flare Regimen Administered to Poor Responders Undergoing ART Cycles
by: Robab Davar, et al.
Published: (2009-08-01)

OVARIAN STIMULATION FOR IVF-ET PROCEDURE
by: Robert Medved, et al.
Published: (2002-03-01)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
by: Mu Lv, et al.
Published: (2022-10-01)

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome
by: Batool Hossein Rashidi, et al.
Published: (2015-10-01)

Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
by: Marlene Hager, et al.
Published: (2022-07-01)

Serum Oestradiol Pattern during Coasting is Different in Antagonist Cycles Compared with Long Agonist Cycles in In Vitro Fertilisation
by: Koray Elter, et al.
Published: (2013-12-01)

Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review
by: Jacques Donnez
Published: (2020-12-01)

Comparison of clinical effects between early follicular prolonged GnRH agonist protocol and GnRH antagonist protocol in 3310 cycles: a retrospective study
by: Juan Gui, et al.
Published: (2022-12-01)

Optimal timing of GnRH antagonist initiation in IVF-ET: a retrospective cohort study on advanced maternal age women
by: Qiao-Song Han, et al.
Published: (2024-02-01)

Ovarian Stimulation with FSH Alone versus FSH plus a GnRH Antagonist for Elective Freezing in an Oocyte Donor/Recipient Programme: A Protocol for a Pilot Multicenter Observational Study
by: Ioannis E. Messinis, et al.
Published: (2023-04-01)

Effect of serum progesterone levels on hCG trigger day on pregnancy outcomes in GnRH antagonist cycles
by: Junwei Zhang, et al.
Published: (2022-09-01)

Live birth rates following individualized dosing algorithm of follitropin delta in a long GnRH agonist protocol
by: Manuel Fernández Sánchez, et al.
Published: (2023-05-01)

Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
by: Moran Shapira, et al.
Published: (2020-06-01)

The Effect of Stimulation Protocols (GnRH Agonist vs. Antagonist) on the Activity of mTOR and Hippo Pathways of Ovarian Granulosa Cells and Its Potential Correlation with the Outcomes of In Vitro Fertilization: A Hypothesis
by: Michail Papapanou, et al.
Published: (2022-10-01)

GnRH Induces ERK-Dependent Bleb Formation in Gonadotrope Cells, Involving Recruitment of Members of a GnRH Receptor-Associated Signalosome to the Blebs
by: Liat Rahamim-Ben Navi, et al.
Published: (2017-06-01)

The role of elagolix in the suppression of ovulation in donor oocyte cycles
by: Catherine Boniface, M.D., et al.
Published: (2023-06-01)

Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol
by: Qijun Xie, et al.
Published: (2024-03-01)

Low-Dose Human Chorionic Gonadotropin Adjunct to an Antagonist Protocol in Assisted Reproductive Technology: a Randomized Trial Study
by: Marzieh Aghahosseini, et al.
Published: (2014-06-01)